Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,538.2
38.4 (1.53%)

 

  • STI Straits Times Index
    2,538.2
    38.4 (1.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,436.8
    -15.3 (-1.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,381.4
    429.2 (1.87%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,837.9
    19.9 (0.71%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,307.6
    565.9 (2.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,609.3
    63.3 (1.39%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 448.9M
  • Value: 563.0M
  • Rise: 198
  • Fall: 70
  • Unch: 540

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.144+0.007
Medtecs Intl0.187+0.010
ThaiBev0.655+0.015
Mapletree Log Tr1.870+0.040
DISA0.001-0.001
3Cnergy0.028+0.004
CapitaMall Trust1.870+0.020
ComfortDelGro1.560+0.020
Reenova Investment^0.002+0.001
Genting Sing0.760+0.005

World Indices

World Indices
Name Last Change
Nasdaq 9,324.6 +39.7
HSI 23,381.4 +429.2
HSCEI 9,614.3 +148.4
Jakarta 4,609.3 +63.3
Nikkei 225 21,286.7 +545.1
SSE Comp 2,837.9 +19.9
Shanghai A 2,974.4 +20.8
Shanghai B 208.0 +4.0
KOSPI 2,027.4 +32.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 26 May 2020 13:06
Last (SGD): 0.188 Change: +0.011 High: 0.188 Remarks: -
Change (%): +6.21 Low: 0.182
Open 0.182 Yesterday's Close 0.177
Buy Price 0.187 Sell Price 0.188
Buy Volume ('000) 276.9 Sell Volume ('000) 804.6
Cumulative Volume ('000) 21,668.0 Cumulative Value 4,033,441
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.00285 NAV (SGD) b 0.1559
PE a 65.965 Trailing PE f 65.999 Price / NAV b 1.2059
Dividend (SGD) d - Cash In Hand (SGD) g 0.0075 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 25.067 Treasury Shares h -
Beta - 75 Daysi 0.060 R-Squared - 75 Days(%)i 0.14 Market Cap (M) 103.289
Beta - 500 Daysi -0.313 R-Squared - 500 Days (%)i 0.14 Enterprise Value (M) 155.989
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) n.a.
52 Weeks Volatility (%) 115.5678 6-Month VWAP 0.119 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 16 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 103.289 65.965 65.999 1.2059 -
Industry Medical & Biotechnology SGX 966.778 20.293 20.525 1.2677 2.190
Medical Specialties SGX 1,718.624 87.940 85.592 9.6238 0.617
Index FTSE ST Catalist Index SGX 64.008 30.063 88.683 0.7829 2.491
Local Peer Top Glove SGX 11,120.397 91.235 88.561 12.5982 0.568
Local Peer Biolidics SGX 101.540 - - 9.3301 -
Local Peer UG Healthcare SGX 69.613 27.778 34.225 1.6390 0.719
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 161,796.709 44.134 45.718 5.3543 1.438
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 134,386.027 36.360 36.627 4.7056 0.226
Global Peer MEDTRONIC PLC NYSE 127,026.150 26.525 26.525 2.5036 2.280
Global Peer DANAHER CORP NYSE 111,892.985 44.959 40.882 3.7987 0.423
Global Peer STRYKER CORP NYSE 69,020.828 33.135 31.895 5.2627 1.158
Global Peer BECTON DICKINSON & CO NYSE 67,834.553 62.694 74.543 3.2381 1.228
Global Peer INTUITIVE SURGICAL INC NASDAQ 65,632.610 47.584 47.344 7.7154 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,250.658 10.692 11.722 3.6403 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 45,196.300 43.172 40.798 11.5855 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,233.113 44.189 43.323 5.7453 0.973
Other Global Peers KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 (NYSE), DEXCOM INC (NASDAQ), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), RESMED INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), HOLOGIC INC (NASDAQ), STERIS PLC (NYSE), MASIMO CORPORATION (NASDAQ), INSULET CORPORATION (NASDAQ), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), QIAGEN NV (NYSE), ABIOMED INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), HARTA (Bursa), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), TOPGLOV (Bursa), HILL-ROM HOLDINGS INC (NYSE), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), PENUMBRA INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), NEVRO CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), AK MEDICAL (HKEx), NUVASIVE INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), ATRICURE INC (NASDAQ), EBOS GROUP (ASX), PEIJIA-B (HKEx), CONMED CORP (NYSE), STAAR SURGICAL CO (NASDAQ), SUPERMX (Bursa), GLAUKOS CORPORATION (NYSE), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CANTEL MEDICAL CORP (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), ATRION CORP (NASDAQ), KDL MEDICAL (HKEx), MESA LABORATORIES INC (NASDAQ), CERUS CORP (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INMODE LTD (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), LIFETECH SCI (HKEx), CRYOLIFE INC (NYSE), ORTHOPEDIATRICS CORP (NASDAQ), INOGEN INC (NASDAQ), HESKA CORP (NASDAQ), CIRC (HKEx), NATUS MEDICAL INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), VAPOTHERM INC (NYSE), ORTHOFIX MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), ZYNEX INC (NASDAQ), QUOTIENT LTD (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), LANTHEUS HOLDINGS INC (NASDAQ), SURMODICS INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), YESTAR HEALTH (HKEx), FLUIDIGM CORP DEL (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), UTAH MEDICAL PRODUCTS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), AXOGEN INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), VIEWRAY INC (NASDAQ), STEREOTAXIS INC (NYSE American), PW MEDTECH (HKEx), IRADIMED CORP (NASDAQ), CORMEDIX INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), INVACARE CORP (NYSE), MISONIX INC (NASDAQ), CUTERA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), DERMTECH INC (NASDAQ), ALPHA PRO TECH (NYSE American), ACCURAY INCORPORATED (NASDAQ), PROFOUND MED CORP (NASDAQ), SIENTRA INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), GOLDEN MEDITECH (HKEx), RETRACTABLE TECHNOLOGIES INC (NYSE American), TELA BIO INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), MODERN DENTAL (HKEx), SOLITON INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), FONAR CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), INTRICOM CORP (NASDAQ), ELECTROMED INC (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ONCOCYTE CORP (NYSE American), CELSION CORPORATION (NASDAQ), RESAPP HEALTH LIMITED (ASX), VOLITIONRX LIMITED (NYSE American), BIOMERICA INC (NASDAQ), CYCLOPHARM LIMITED (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), NEPHROS INC (NASDAQ), YUNNAN ENERGY (HKEx), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), CONFORMIS INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), VINCENT MED (HKEx), COMPUMEDICS (ASX), SDI LTD (ASX), DAXOR CORP (NYSE American), SOMNOMED LIMITED (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), LKL (Bursa), EMVISION MEDICAL DEVICES LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), ELLEX MEDICAL LASERS LTD (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), KELFRED (HKEx), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), IMPEDIMED LIMITED (ASX), NEURONETICS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ELECTROCORE INC (NASDAQ), MICRO-X LTD (ASX), DIMERIX LTD (ASX), NEOVASC INC (NASDAQ), IMMUCELL CORP (NASDAQ), RESPIRI LTD (ASX), NEUROTROPE INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), DARIOHEALTH CORP (NASDAQ), IMPRESSION HEALTHCARE LIMITED (ASX), OVENTUS MEDICAL LTD (ASX), IRIDEX CORP (NASDAQ), LBT INNOVATIONS LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), LIFE HEALTHCARE (HKEx), EKSO BIONICS HOLDINGS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CHECK-CAP LTD (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), BIOLASE INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), ENDOLOGIX INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), OPTISCAN IMAGING (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CYANOTECH CORP (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), AETHLON MEDICAL INC (NASDAQ), CARDIEX LTD (ASX), MYOS RENS TECHNOLOGY INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), AVINGER INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), DYNATRONICS CORP (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), SINTX TECHNOLOGIES INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), ADHERIUM LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE), INSPIREMD INC (NYSE American), OBALON THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), STHAI (SET), DIGIRAD CORP (NASDAQ), ANALYTICA (ASX), METALICITY LIMITED (ASX), DORSAVI LTD (ASX), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.001
+0.53 %
10 Days -+0.012
+6.82 %
20 Days -+0.072
+62.07 %
Medium Term Return 3 Months -+0.091
+93.81 %
6 Months -+0.151
+408.11 %
1 Year -+0.163
+652.00 %
Long Term Return 2 Years -+0.145
+337.21 %
3 Years -+0.139
+283.67 %
5 Years -+0.130
+224.14 %
Annualised Return Annualised --
+26.52 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.022 - 0.210 Change From 1 Year Low +0.166 % Change From 1 Year Low (%) +754.55
Change From 1 Year High -0.022 % Change From 1 Year High (%) -10.48
2 Years Range 0.022 - 0.210 Change From 2 Years Low +0.166 % Change From 2 Years Low (%) +754.55
Change From 2 Years High -0.022 % Change From 2 Years High (%) -10.48
5 Years Range 0.022 - 0.210 Change From 5 Years Low +0.166 % Change From 5 Years Low (%) +754.55
Change From 5 Years High -0.022 % Change From 5 Years High (%) -10.48
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) -25.10 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
22 May 2020 0.185 0.186 0.177 0.177 18,172,200 0.1803
21 May 2020 0.191 0.192 0.184 0.184 16,400,300 0.1878
20 May 2020 0.187 0.192 0.185 0.189 27,694,100 0.1891
19 May 2020 0.188 0.190 0.182 0.185 27,583,600 0.1856
18 May 2020 0.191 0.192 0.186 0.189 18,431,500 0.1895
15 May 2020 0.194 0.196 0.187 0.187 37,572,900 0.1920
14 May 2020 0.183 0.194 0.180 0.192 54,176,000 0.1892
13 May 2020 0.188 0.197 0.184 0.184 91,103,300 0.1910
12 May 2020 0.178 0.193 0.172 0.191 68,366,400 0.1831
11 May 2020 0.185 0.187 0.174 0.178 54,429,100 0.1801
08 May 2020 0.164 0.193 0.161 0.176 196,689,200 0.1770
06 May 2020 0.142 0.162 0.137 0.158 167,884,400 0.1497
05 May 2020 0.110 0.117 0.109 0.114 22,925,300 0.1136
04 May 2020 0.105 0.110 0.105 0.108 5,917,400 0.1081
30 Apr 2020 0.109 0.112 0.108 0.109 9,575,000 0.1095
29 Apr 2020 0.112 0.113 0.108 0.108 14,942,400 0.1097
28 Apr 2020 0.113 0.118 0.111 0.112 20,608,300 0.1146
27 Apr 2020 0.116 0.118 0.111 0.113 6,995,700 0.1145
24 Apr 2020 0.116 0.120 0.112 0.116 18,972,900 0.1160
23 Apr 2020 0.137 0.137 0.104 0.112 99,906,900 0.1262
22 Apr 2020 0.100 0.148 0.100 0.130 184,293,000 0.1232
21 Apr 2020 0.101 0.102 0.096 0.099 29,619,600 0.0994
Summary
Current 2 Weeks
(11 May 2020 to 22 May 2020)
0.185 0.197 0.172 0.177 413,929,400 -
Previous 2 Weeks
(23 Apr 2020 to 08 May 2020)
0.137 0.197 0.104 0.176 564,417,500 -
4 Weeks from
(25 Mar 2020 to 22 Apr 2020)
0.074 0.197 0.071 0.130 652,517,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.